Learn about Multiple Myeloma Diagnosis. Explore bone marrow biopsies, genetic testing (FISH), and PET-CT imaging used at Liv Hospital for precise evaluation.
Send us all your questions or requests, and our expert team will assist you.
Diagnosis and Evaluation
Receiving a potential diagnosis of multiple myeloma can be a time of intense anxiety and uncertainty. Accurate diagnosis is the cornerstone of effective treatment; it determines not just if you have the condition, but specifically which type and how aggressive it might be.
At Liv Hospital, we utilize a comprehensive, multi-step diagnostic approach. We move beyond simple blood tests to employ advanced genetic profiling and high-resolution imaging. This allows our multidisciplinary team of hematologists and pathologists to construct a detailed “roadmap” of the disease, ensuring that your treatment plan whether it involves novel drug therapies or stem cell transplantation is perfectly tailored to your unique biological profile.
This guide explains the specific tests used to confirm multiple myeloma, what to expect during a bone marrow biopsy, and how doctors determine the stage of the disease.
Diagnosing multiple myeloma is no longer just about confirming the cancer; it is about understanding its genetic behavior. This is called Risk Stratification.
Once the bone marrow sample is obtained, we perform Fluorescence In Situ Hybridization (FISH) and Cytogenetic Analysis. These advanced tests look for specific chromosomal changes in the myeloma cells, such as:
Why This Matters: Patients with “High-Risk” genetic markers may require more aggressive initial therapy or a tandem stem cell transplant, while “Standard-Risk” patients may respond excellently to conventional protocols. This personalized genetic insight is vital for long-term success.
Myeloma cells can weaken bones, causing “lytic lesions” (soft spots) or fractures that might not be immediately painful. Accurate imaging helps us see the extent of the disease throughout the skeleton.
The diagnostic journey often begins with blood work. Unlike solid tumors that form a lump, multiple myeloma is a cancer of the plasma cells in the blood and marrow. Therefore, the chemical signature of the disease is often found circulating in your system.
Key Laboratory Tests:
While blood tests provide strong clues, a bone marrow biopsy is the “gold standard” for a definitive diagnosis. We understand that the thought of this procedure can be frightening for many patients. At Liv Hospital, we prioritize your comfort, using local anesthesia and sedation options to minimize discomfort.
The Procedure Steps:
This procedure is quick, typically taking less than 20 minutes, and is performed on an outpatient basis.
Send us all your questions or requests, and our expert team will assist you.
Time is often a critical factor for international patients. At Liv Hospital, our diagnostic infrastructure is designed for speed and accuracy.
Staging helps the medical team understand how much cancer is in the body and the likely prognosis. Multiple Myeloma is staged using the Revised International Staging System (R-ISS), which combines three factors:
The Stages:
Most patients report pressure rather than sharp pain. We use a local anesthetic to numb the skin and the surface of the bone. For anxious patients, mild sedation is available to ensure the procedure is as comfortable as possible. You may feel a brief, sharp sensation during the aspiration, but it lasts only seconds.
No. While high levels of M protein in the blood strongly suggest myeloma, a definitive diagnosis requires proving that there are excess plasma cells in the bone marrow (via biopsy) or proving related organ damage (via imaging and blood tests).
Standard pathology results are usually available within 2-3 days. However, complex genetic tests like FISH and cytogenetics may take 5-7 days because the cells need time to grow in the lab. We expedite these for our international patients to begin treatment immediately.
An MRI is best for looking at details of the bone and spinal cord structure. A PET scan looks at cellular activity; it shows where cancer cells are actively consuming energy. We often use both to get a complete picture.
Not necessarily. We can review your existing pathology slides and imaging discs. However, if the genetic profiling (FISH) was not comprehensive or if the images are outdated, we may recommend repeating specific tests to ensure your treatment plan is based on the most current data.
Your Comparison List (you must select at least 2 packages)
